BioSpace News Archive

Drug Development

Servier, Taiho Oncology Prep to Submit Cancer Drug Combo to FDA

Servier and Taiho Oncology announced Tuesday that Lonsurf in combination with bevacizumab improved overall survival rates in patients with refractory metastatic colorectal cancer.

January 18, 2023
·
1 min read
·
Hayley Shasteen
Drug Development

Junshi’s Phase III PD-1 Blocker Shows Promise in NSCLC

A pre-specified interim analysis of Junshi Biosciences’ Phase III Neotorch trial showed its anti-PD-1 monoclonal antibody, toripalimab, met its primary endpoint in non-small cell lung cancer (NSCLC).

January 18, 2023
·
2 min read
·
Tristan Manalac
Drug Development

Moderna’s RSV Vaccine Snags FDA Breakthrough Therapy Nod

The FDA granted Moderna’s RSV vaccine candidate Breakthrough Therapy Designation Monday.

January 18, 2023
·
1 min read
·
Cory Renauer and Heather McKenzie
Drug Development

Horizon Bags Second Phase II Win in Sjögren’s Syndrome

Horizon Therapeutics’ dazodalibep met the primary endpoint in a second straight Phase II trial for Sjögren’s syndrome.

January 18, 2023
·
2 min read
·
Tristan Manalac
Policy

FTC Seeks to Ban Non-Competes Nationwide, Singles Out BioPharma

The FTC issued a Notice of Proposed Rulemaking (NPRM) that could change the landscape for employer-employee relationships nationwide, specifically in the biopharma industry.

January 18, 2023
·
5 min read
·
Rosemary Scott
Policy

Despite Regulatory Progress, Delivery Hurdles Persist for Neurodegenerative Space

The neurodegenerative drug development space saw incremental victories in 2022. Leaders from Eisai, Voyager and QurAlis discuss upcoming milestones.

January 18, 2023
·
4 min read
·
Heather McKenzie
Drug Development

Phase II Terminations Climb as Breast Cancer Remains Most Studied in 2022

Breast cancer came in as the most studied disease in 2022, according to the patient data analytics firm Phesi.

January 18, 2023
·
2 min read
·
Kate Goodwin
Business

Nicox Provides Fourth Quarter 2022 Financial Highlights

Nicox SA, an international ophthalmology company, provided financial highlights for the fourth quarter 2022 for Nicox SA and its subsidiaries.

January 18, 2023
·
5 min read
Business

Oncopeptides Chief Financial Officer Holger Lembrer takes office today

Oncopeptides AB announces that Holger Lembrer, who recently was appointed Chief Financial Officer, CFO, takes the office on January 18.

January 18, 2023
·
2 min read
Business

Longevity Biotech Gero Entered a Research Collaboration With Pfizer to Discover Potential Targets for Fibrotic Diseases

Gero announced that it has entered into a research collaboration with Pfizer to apply Gero’s machine learning technology platform to discover potential therapeutic targets for fibrotic diseases using large-scale human-based data.

January 18, 2023
·
2 min read